QA: Kalvista Pharmaceuticals Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001348911_2018_Kalvista_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001348911, Kalvista Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 34,198,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 97,000
3 remainder_Assets 50,000
4 LiabilitiesCurrent 3,018,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,177,000
9 ResearchAndDevelopmentExpense 12,666,000
10 remainder_Expenses 0
11 remainder_Revenues 1,504,000
12 remainder_NetIncome 3,736,000
13 remainder_ComprehensiveNetIncome -2,568,000
  yvar yval
0 Assets 34,345,000
1 Liabilities 3,018,000
2 Expenses 23,843,000
3 Revenues 1,504,000
4 StockholdersEquity 31,327,000
5 NetIncome -18,603,000
6 ComprehensiveNetIncome -19,887,000
7 BaseVar 34,507,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.59
9 EconomicCapitalRatio 3.42

Edgar->Model Mapping

Feature Distribution

Change over Time